Former Google CEO to serve on federal biotech commission

Former Google CEO Eric Schmidt will serve on the National Security Commission on Emerging Biotechnology, CNBC reported Jan. 31.

Advertisement

Mr. Schmidt holds stakes in several biotech companies through venture capital firm First Spark Ventures. He will not have to divest from any of his investments in this role.

The committee reviews the biotech industry and suggests ways to improve U.S. national security. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.